CMS of­fi­cial on Alzheimer's drug cov­er­age de­ci­sion: Don't read be­tween the lines for oth­er ac­cel­er­at­ed ap­provals

Al­most a week af­ter fi­nal­iz­ing its re­stric­tive de­ci­sion for amy­loid-tar­get­ed Alzheimer’s drugs, the Cen­ters for Medicare and Med­ic­aid Ser­vices (CMS) now ap­pears to be walk­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER